We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$18.2B
AUM Growth
+$1.82B
Cap. Flow
-$2.99B
Cap. Flow %
-16.46%
Top 10 Hldgs %
22.85%
Holding
740
New
145
Increased
222
Reduced
105
Closed
59
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZBRA icon
426
Zebra Technologies
ZBRA
$12.5B
$482K ﹤0.01%
+2,725
New +$437K
LPLA icon
427
LPL Financial
LPLA
$26.5B
$480K ﹤0.01%
7,440
+4,290
+136% +$284K
CACC icon
428
Credit Acceptance
CACC
$5.88B
$462K ﹤0.01%
+1,055
New +$443K
NGVT icon
429
Ingevity
NGVT
$2.54B
$451K ﹤0.01%
+4,425
New +$427K
BAH icon
430
Booz Allen Hamilton
BAH
$8.68B
$449K ﹤0.01%
+9,045
New +$441K
IEFA icon
431
iShares Core MSCI EAFE ETF
IEFA
$187B
$445K ﹤0.01%
6,950
-32,138
-82% -$2.05M
IRMD icon
432
iRadimed
IRMD
$1.22B
$436K ﹤0.01%
+11,740
New +$317K
CBSH icon
433
Commerce Bancshares
CBSH
$8.54B
$430K ﹤0.01%
+9,618
New +$449K
TCF
434
DELISTED
TCF Financial Corporation
TCF
$428K ﹤0.01%
+17,990
New +$456K
CTXS
435
DELISTED
Citrix Systems Inc
CTXS
$427K ﹤0.01%
+3,840
New +$425K
QDEL icon
436
QuidelOrtho
QDEL
$1.16B
$422K ﹤0.01%
+6,470
New +$452K
EVR icon
437
Evercore
EVR
$13B
$421K ﹤0.01%
+4,190
New +$452K
LGND icon
438
Ligand Pharmaceuticals
LGND
$5.96B
$420K ﹤0.01%
+2,453
New +$370K
PGTI
439
DELISTED
PGT, Inc.
PGTI
$419K ﹤0.01%
+19,380
New +$452K
GNRC icon
440
Generac Holdings
GNRC
$11.4B
$418K ﹤0.01%
+7,410
New +$406K
INGN icon
441
Inogen
INGN
$172M
$415K ﹤0.01%
+1,700
New +$393K
ARCB icon
442
ArcBest
ARCB
$3.24B
$412K ﹤0.01%
+8,490
New +$399K
HAE icon
443
Haemonetics
HAE
$3.63B
$412K ﹤0.01%
+3,600
New +$373K
MEDP icon
444
Medpace
MEDP
$16.5B
$412K ﹤0.01%
+6,870
New +$376K
SKYW icon
445
Skywest
SKYW
$4.33B
$412K ﹤0.01%
+7,000
New +$414K
THC icon
446
Tenet Healthcare
THC
$21.2B
$412K ﹤0.01%
+14,490
New +$478K
IR icon
447
Ingersoll Rand
IR
$32.8B
$411K ﹤0.01%
+14,490
New +$406K
GHDX
448
DELISTED
Genomic Health, Inc.
GHDX
$410K ﹤0.01%
+5,840
New +$342K
HEES
449
DELISTED
H&E Equipment Services
HEES
$408K ﹤0.01%
+10,810
New +$391K
WMS icon
450
Advanced Drainage Systems
WMS
$10.8B
$408K ﹤0.01%
+13,220
New +$401K

Similar funds

Calamos Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, Calamos Advisors held 740 positions worth $18.2B, up 11% from $16.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Calamos Advisors withdrew a net $2.99B in Q3 2018, closing 59 positions and reducing 105 holdings. Its most notable exit was NextEra Energy, Inc., an estimated $56.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 11% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Calamos Advisors opened a new position in Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A worth $67.9M.

  • Calamos Advisors's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 62,956 shares worth $67.9M.
  • Calamos Advisors added most to Charles Schwab in Q3 2018, an estimated $44M increase.
  • Calamos Advisors's biggest Q3 2018 reduction was Philip Morris, cutting an estimated $46.2M.
  • Calamos Advisors fully exited NextEra Energy, Inc. in Q3 2018, selling an estimated $56.2M.
  • Calamos Advisors's ten largest holdings make up 23% of its $18.2B portfolio in Q3 2018.
  • Calamos Advisors opened 145 new positions and closed 59 in Q3 2018.
  • Calamos Advisors's portfolio value rose 11% quarter-over-quarter to $18.2B.

Based on Calamos Advisors's 13F filing for Q3 2018, filed 22 Oct 2018.